Ramkhamhaeng Hospital Public Company Limited - Depositary Receipt (Common Stock) - Income Statement (TTM)

Ramkhamhaeng Hospital Public Company Limited - Depositary Receipt (Common Stock)
TH ˙ SET ˙ TH0259010R10
Income Statement (TTM)

Ramkhamhaeng Hospital Public Company Limited - Depositary Receipt (Common Stock) Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.

All numbers are times 1,000,000 except per share units.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 6,725 7,826 7,902 8,725 11,688 12,664 13,473 13,515 11,484 10,687 9,953 9,834 9,660 9,634 9,759 9,630 9,796 9,868 10,148 10,346
Change (%) 16.37 0.97 10.41 33.97 8.35 6.39 0.31 -15.03 -6.94 -6.86 -1.20 -1.77 -0.27 1.30 -1.33 1.72 0.74 2.84 1.96
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 5,777 6,785 6,819 6,988 7,895 7,941 8,247 8,376 7,732 7,810 7,546 7,471 7,407 7,461 7,517 7,485 7,619 7,532 7,762 7,846
Change (%) 17.45 0.50 2.48 12.98 0.59 3.85 1.57 -7.69 1.01 -3.38 -1.00 -0.85 0.72 0.76 -0.42 1.79 -1.15 3.05 1.09
% of Revenue 85.91 86.70 86.29 80.09 67.54 62.71 61.21 61.98 67.33 73.09 75.82 75.97 76.68 77.44 77.02 77.73 77.78 76.33 76.49 75.83
Gross Operating Profit 948 1,041 1,083 1,737 3,794 4,723 5,226 5,139 3,751 2,876 2,407 2,363 2,253 2,174 2,242 2,144 2,177 2,336 2,386 2,501
Change (%) 9.79 4.09 60.35 118.42 24.50 10.65 -1.67 -27.00 -23.33 -16.31 -1.83 -4.66 -3.52 3.17 -4.38 1.51 7.33 2.13 4.81
% of Revenue 14.09 13.30 13.71 19.91 32.46 37.29 38.79 38.02 32.67 26.91 24.18 24.03 23.32 22.56 22.98 22.27 22.22 23.67 23.51 24.17
SG&A 1,000 1,242 1,225 1,274 1,362 1,364 1,397 1,419 1,481 1,513 1,582 1,592 1,607 1,559 1,475 1,425 1,385 1,441 1,449 1,497
Change (%) 24.13 -1.33 4.03 6.84 0.16 2.43 1.56 4.40 2.12 4.61 0.58 0.99 -2.99 -5.41 -3.36 -2.83 4.08 0.51 3.36
% of Revenue 14.87 15.87 15.50 14.61 11.65 10.77 10.37 10.50 12.90 14.16 15.90 16.19 16.64 16.18 15.11 14.80 14.14 14.61 14.28 14.47
R&D
Change (%)
% of Revenue
OpEx 6,777 8,027 8,044 8,262 9,257 9,305 9,644 9,795 9,214 9,323 9,129 9,062 9,014 9,020 8,992 8,911 9,004 8,973 9,210 9,343
Change (%) 18.43 0.21 2.72 12.03 0.52 3.64 1.57 -5.94 1.19 -2.09 -0.73 -0.53 0.06 -0.31 -0.90 1.05 -0.34 2.65 1.44
% of Revenue 100.78 102.57 101.80 94.70 79.19 73.48 71.58 72.48 80.23 87.24 91.72 92.16 93.32 93.62 92.14 92.53 91.92 90.93 90.76 90.30
Operating Income -52 -201 -142 462 2,432 3,359 3,829 3,720 2,270 1,363 825 771 646 614 768 719 792 895 937 1,003
Change (%) 283.23 -29.39 -425.64 425.99 38.13 13.98 -2.85 -38.98 -39.94 -39.53 -6.45 -16.32 -4.83 24.95 -6.34 10.10 13.02 4.76 7.05
% of Revenue -0.78 -2.57 -1.80 5.30 20.81 26.52 28.42 27.52 19.77 12.76 8.28 7.84 6.68 6.38 7.86 7.47 8.08 9.07 9.24 9.70
Interest Expense -175 -211 -221 -227 -232 -239 -237 -235 -240 -243 -262 -284 -305 -332 -363 -390 -415 -429 -423 -404
Change (%) 20.68 4.93 2.66 1.88 3.34 -1.15 -0.60 1.90 1.57 7.70 8.47 7.31 8.91 9.17 7.46 6.55 3.21 -1.36 -4.51
% of Revenue -2.60 -2.70 -2.80 -2.61 -1.98 -1.89 -1.76 -1.74 -2.09 -2.28 -2.63 -2.89 -3.16 -3.45 -3.72 -4.05 -4.24 -4.34 -4.17 -3.90
Net Income 1,043 1,271 511 1,088 2,807 4,171 4,552 4,596 3,563 2,174 1,722 1,648 1,515 1,551 1,627 1,433 1,292 728 729 715
Change (%) 21.84 -59.82 113.07 157.96 48.60 9.12 0.99 -22.49 -38.98 -20.80 -4.26 -8.10 2.40 4.90 -11.95 -9.83 -43.67 0.15 -1.92
% of Revenue 15.51 16.24 6.46 12.47 24.01 32.94 33.78 34.01 31.02 20.34 17.30 16.76 15.68 16.10 16.67 14.88 13.19 7.38 7.18 6.91

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista